Join
Live feed
·
INSIDERFilingvia Quantisnow
Turn Therapeutics Inc. logo

Officer Chaudhary Zuraiz bought $7,074 worth of shares (2,450 units at $2.89), increasing direct ownership by 32% to 10,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTRX (Turn Therapeutics Inc.) and more on Quantisnow.